Author: therawinformant

Southwest Airlines Co. (LUV) said it has priced its public offering of $1.8 billion of debt in two tranches.The U.S. carrier will offer to sell $500 million aggregate principal amount of 4.750% notes due 2023 and $1.3 billion aggregate principal amount of 5.125% notes due 2027. The 2027 notes will be issued at par value.Southwest Airlines said it expects to use the net proceeds from the offering to repay all of its outstanding debt under its 364-day credit agreement and for general corporate purposes. Upon repayment, it will terminate the credit agreement. The offering is expected to close by June 8, 2020, subject to customary closing conditions.The U.S. carrier added that the 2023 bonds are being offered as an additional issuance of its 4.750% notes due 2023, of which it sold $750 million aggregate principal amount on May 4. The notes are part of the same class as the initial notes of that series and have identical terms, other than the issue date and issue price.Stringent travel restrictions tied to the coronavirus pandemic have brought travel demand to an almost halt, slashing the value of Southwest Airlines’ shares in half this year. U.S. airlines have been burning through billions of dollars in the first quarter incurring huge losses and implementing cost-cutting plans, as well as taking steps to shore up its cash buffers to cope with the financial fallout.Over the past month, Southwest Airlines stock has seen some relief after reporting that in the month through May 18, it recorded net positive bookings reversing net negative booking trends prevalent during most of March and April, where trip cancellations outpaced new passenger bookings.Furthermore, Southwest Airlines expects to bring down average daily cash burn in June to be in the low-$20 million compared with average daily core cash spending of $30 million to $35 million in the second quarter.Last week, five-star analyst Myles Walton at UBS lifted his rating on the stock to a Buy, saying that the U.S. carrier offers the “best risk/reward” for a recovery.Meanwhile, Cowen & Co. analyst Helane Becker reiterated a Buy rating on the shares, citing Southwest’s financial strength and leisure focus.Becker believes that looking ahead to a reopening of the aviation industry, consumers are more likely to take a short-haul domestic flight than to book a trip to Europe.“The industry may still be able to salvage some of the summer season,” Becker said.Overall, Wall Street analysts are cautiously optimistic on the stock. The 13 analyst ratings are divided between 9 Buys and 4 Holds adding up to a Moderate Buy consensus. The $40.22 average price target indicates 10% upside potential in the shares in the coming 12 months. (See Southwest Airlines stock analysis on TipRanks).Related News: S&P Cuts American Airlines’ Credit Rating To ‘B-‘ from ‘B’ On Cash Flow Deficit Concern Billionaire Investor Dan Loeb’s Fund Lists Boeing As Top Winner In May Amazon Leases 12 Boeing Cargo Aircraft To Meet Online Orders Surge More recent articles from Smarter Analyst: * AstraZeneca Partners With Accent To Develop Novel Cancer Treatments * Nio Rising On Record-High Monthly Deliveries, Goldman Sachs Upgrade * Inovio Suing Suppliers Over Covid-19 Vaccine Production * S&P; Cuts American Airlines’ Credit Rating To 'B-' from 'B' On Cash Flow Deficit Concern

from Yahoo Finance https://ift.tt/2XYK2dF

Pilgrim’s Pride CEO and 3 other chicken producer executives have been indicted over allegations of price-fixing. Yahoo Finance’s Heidi Chung joins Zack Guzman to discuss.

from Yahoo Finance https://ift.tt/374TJLK

China’s electric vehicle maker Nio Inc (NIO) has revealed that it delivered 3,436 vehicles in May 2020, representing a strong 215.5% growth year over year. Shares are now rising 3% in Thursday’s pre-market trading.The deliveries consisted of 2,685 ES6s, the company’s 5-seater high-performance premium smart electric SUV, and 751 ES8s, the company’s 7-seater high-performance premium smart electric SUV and its 6-seater variant.As of May 31, 2020, cumulative deliveries of the ES8 and the ES6 reached 42,342 vehicles, of which 10,429 were delivered in 2020, NIO said.“In May, we achieved record-high monthly deliveries in our history” cheered William Bin Li, founder and CEO of NIO. He stated that the company “will further increase our production capacity and expand our sales network to support our future growth.”Meanwhile Steven Feng, chief financial officer of NIO, added, “We are pleased to see the strong monthly deliveries despite fewer working days due to the public holiday in May. We expect to achieve the delivery goal for the second quarter 2020, while continuously improving gross margin and narrowing operating loss.”In a further bullish signal NIO rallied 19% on June 3 after the stock received an upgrade from Goldman Sachs analyst Fei Fang. This comes on the back of rating upgrades from JP Morgan and Merrill Lynch.Fang boosted the stock from hold to buy with a $6.40 price target (14% upside potential). “We believe ES6 and ES8 volume strength has transitioned from being promotion-driven to reputation-driven,” Fang told investors, adding that never before has a domestic premium Chinese auto brand had a waiting list.With NIO stock enjoying a 39% year-to-date gain, analysts have a cautiously optimistic Moderate Buy consensus and an average analyst price target of $5.70 (2% upside potential). (See Nio stock analysis on TipRanks).Related News: Lyft Rises 5% After-Hours On Strong May Performance Can Tesla Provide the Million Mile EV Battery? Top Analyst Weighs In Uber In Partnership With MoneyGram For Driver Discount During Pandemic More recent articles from Smarter Analyst: * AstraZeneca Partners With Accent To Develop Novel Cancer Treatments * Inovio Suing Suppliers Over Covid-19 Vaccine Production * S&P; Cuts American Airlines’ Credit Rating To 'B-' from 'B' On Cash Flow Deficit Concern   * FedEx Adding Temporary Surcharges As Covid-19 Pressures Mount

from Yahoo Finance https://ift.tt/3gUsb07

Starting June 8, FedEx (FDX) has announced that it will start implementing a number of surcharges, including a temporary surcharge on FedEx SmartPost packages of $0.4/ package, as it deals with the fallout from Covid-19.For customers at the enterprise level, U.S. domestic residential FedEx Express and FedEx Ground packageswill face a surcharge of $0.3/ package, while Oversize U.S. domestic FedEx Express and FedEx Ground packages will now need to cough up an extra $30/ package.“As the impact of the virus continues to generate a surge in residential deliveries and has also generated a surge in oversize, hard-to-handle packages, we have experienced increased operating costs across our network” the company explained.“To continue providing our customers with strong levels of service during this time, we are implementing temporary peak surcharges” FedEx stated, arguing that it provides an essential business keeping commerce moving and delivering critical shipments during this challenging time.Indeed, FedEx rival UPS (UPS) has already implemented peak surcharges on certain U.S. domestic packages starting from May 31, and effective until further notice. “Our goal is to ensure businesses and customers are able to meet their shipping needs while demand has increased for shipping services” the company explained at the time.A $0.30 peak surcharge now applies to certain UPS Ground Residential and UPS SurePost packages if customer’s (like Amazon, Best Buy and Target) average weekly volume exceeds 25,000 packages.Shares in FedEx are currently trading down 9% year-to-date. Analysts have a cautiously optimistic Moderate Buy consensus on the stock, with 10 recent buy ratings offset by 8 hold ratings. More worryingly, the average analyst price target of $135 indicates 2% downside potential from current levels. (See FDX stock analysis on TipRanks).Morgan Stanley’s Ravi Shanker has just reiterated his hold rating on FedEx, citing unprecedented pressures from Covid-19 including sharp declines in B2B and International volumes, elevated costs and one fewer working day.Related News: Zoom Lifts Full-Year Sales Guidance As Quarterly Revenue Balloons 169% Billionaire Ackman Exits Berkshire Hathaway, Blackstone To Fund Opportunities Amazon Leases 12 Boeing Cargo Aircraft To Meet Online Orders Surge More recent articles from Smarter Analyst: * AstraZeneca Partners With Accent To Develop Novel Cancer Treatments * Nio Rising On Record-High Monthly Deliveries, Goldman Sachs Upgrade * Inovio Suing Suppliers Over Covid-19 Vaccine Production * S&P; Cuts American Airlines’ Credit Rating To 'B-' from 'B' On Cash Flow Deficit Concern

from Yahoo Finance https://ift.tt/3dJImLP

Inovio Pharmaceuticals (INO) has now initiated legal proceedings as an emergency action to compel the technology transfer required for the planned large-scale manufacture of its COVID-19 vaccine candidate.The company has an ambitious goal of producing one million doses of INO-4800 by the end of 2020, with its existing capacity and contract resources, for further clinical trials or emergency use.To fulfil this goal, INO has filed a complaint in Pennsylvania to compel VGXI, Inc. and GeneOne Life Science to facilitate the transfer of manufacturing methods, using VGXI’s technology, to the company’s new engaged contract manufacturers.“The Company believes that widespread availability of its potential COVID-19 vaccine, which can only be achieved through accelerated large-scale manufacture following clinical trials and regulatory approval, is essential to combat the ongoing global coronavirus pandemic” INO states.Under the companies’ Supply Agreement, VGXI produces and supplies the DNA plasmids for the INO’s research and early clinical trials for its product candidates.However VGXI allegedly informed Inovio that it did not have the capacity to manufacture the full order of DNA plasmids on the requested timeline, nor would it be able to manufacture plasmids for the commercial sale of INO-4800, if the vaccine were approved.It subsequently refused to transfer the technology to INO’s third party contract manufacturers.In January 2020, INO began preclinical studies of INO-4800, and in April it received approval from the U.S. FDA to begin a Phase 1 clinical trial of INO-4800. If the initial safety and immunogenicity data from the Phase 1 trial are acceptable, INO plans to advance the development of INO-4800 into later-stage efficacy trials in the second half of 2020.In a further dose of bad news, Inovio has not been selected by the Trump administration as one of the five companies picked to develop a COVID-19 vaccine as part of the government’s Warp Speed operation. The companies selected will receive additional government funding, assistance in clinical development and manufacturing to ensure the availability of two hundred million doses by YE2020.“Given INO’s notable omission from this list, we see these developments as a negative read-through to INO shares, though we would await a formal announcement, given INO’s need for external funding in further clinical development and manufacturing scale-up of their ph.I candidate, INO-4800” commented RBC Capital analyst Gregory Renza. Indeed, shares fell 13% on June 3, and are now falling 5% in Thursday’s pre-market trading.However the anlayst adds “While the news can be seen as initially disappointing… we think the announcement would not preclude INO from an ultimately successful development of a COVID-19 vaccine as they continue to leverage external funding support funding and maintain active engagement with gov’t agencies and other funders.”Renza reiterated his Hold rating on the stock with a $10 price target (20% downside potential) on June 3. INO stock has exploded over 270% year-to-date, and analysts have a cautiously optimistic Moderate Buy consensus on the stock’s outlook. That’s with a $17 average analyst price target for further upside potential of 34%. (See INO stock analysis on TipRanks).Related News: 5 Covid-19 Vaccines Picked For Trump’s Operation Warp Speed Inovio’s COVID-19 Vaccine Candidate Has the Edge Over Moderna’s, Says 5-Star Analyst Novavax Seeks To Make 1 Billion Covid-19 Vaccine Doses More recent articles from Smarter Analyst: * S&P; Cuts American Airlines’ Credit Rating To 'B-' from 'B' On Cash Flow Deficit Concern   * FedEx Adding Temporary Surcharges As Covid-19 Pressures Mount * Uber CEO Reveals Pickup In May Rides As Covid-19 Restrictions Ease * Billionaire Investor Dan Loeb’s Fund Lists Boeing As Top Winner In May

from Yahoo Finance https://ift.tt/2z2dvLf

(Bloomberg) — Oil traders and analysts scrutinizing U.S. inventory data for signs of a market recovery are being confronted by an odd situation: the math just doesn’t add up.Various government data sets including stockpiles, production, imports and exports are signaling that current official figures on at least some supplies are excessive. While it’s unclear where exactly the discrepancy lies, the difference could potentially signal a more bullish outlook for crude prices as they claw their way back after diving below zero in April.The excess is showing up in the U.S. Energy Information Administration’s so-called crude supply adjustment factor — the difference between stockpile numbers and those implied by production, refinery demand, imports and exports. That has averaged negative 980,000 barrels daily over the past four weeks — the largest in records going back to 2001, and equivalent to more than 27 million barrels.The adjustment factor tends to swing back and forth, depending on irregularities in various surveys the EIA pulls from for its reports. For these weekly reports, the EIA is not able to collect domestic crude oil production, instead estimating it from its short-term energy outlook model.Some investors lay the blame for the current discrepancy on U.S. oil production numbers. While daily output fell 700,000 barrels to 11.2 million in May, they believe oil’s plunge into negative territory in April should have led to a steeper decline.Just last month, consultancy IHS Markit said that U.S. oil producers are in the process of curtailing 1.75 million barrels a day of existing output by early June due to operating cash losses, lack of demand and storage capacity and an unwillingness to sell resources at low prices. Some of that lower production is already becoming evident, according to information disclosed in various company announcements and state data.Read: No One Expected U.S. Shale Oil Output Cuts to Happen So FastWhile output may be a factor, it’s unlikely the full answer. According to the EIA’s Robert Merriam, the accuracy of its production modeling compared to subsequent monthly data has been good, often within 1-2% in most months.Since prices started tumbling in March following the collapse of the OPEC+ deal to cut output, the EIA’s weekly data has recorded a production decline of 1.9 million barrels, which he said was substantial compared with historical numbers. And while he’s also seen a wide range of analyst estimates on current production volumes, it’s not clear whether those are comprehensive or extrapolated.“The adjustment reflects the aggregate uncertainty around each of the supply and disposition elements, and the crude production estimate certainly remains but one potential factor,” Merriam, the director of the Office of Energy Production, Conversion, and Delivery at the EIA, said.He said that there have also some large weekly swings in reported inventory levels and refinery runs, so all the elements within the crude data are moving around far more than they usually do, adding that “the timing of reporting those could also be driving the adjustment lately, as they always do.”A year ago, the crude adjustment factor caught the attention of energy enthusiasts when the figure was more than 800,000 barrels a day for four weeks, implying the reverse — that something in the data was undercounted. The EIA, at the time, had suspected that besides understating oil production, one of the reasons was plant condensate that was associated with natural gas output, but blended into the crude oil stream.For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/3716IOr

(Bloomberg) — The grand alliance that’s helped revive global oil markets is being rattled by a long-running feud over members breaking their promises.Just a day before a proposed gathering on Thursday, the OPEC+ coalition hurriedly backtracked from the meeting intended to green-light an extension of its deepest production cutbacks and prop up crude prices.Saudi Arabia and Russia — the leading producers in the group — have lost patience with the errant behavior of the next-biggest member, Iraq, according to people familiar with the matter. While most of the main players are delivering their agreed share of output curbs, Baghdad is once again reneging on its commitments.At stake is the unity of the 23-nation partnership, which has helped engineer a doubling in international oil prices following the battering meted out by the coronavirus crisis. If the Iraqis, and other delinquents such as Nigeria and Kazakhstan, don’t shape up then Riyadh and Moscow are warning they will start to phase out the supply curbs that are putting a floor under the market.The kingdom and the Kremlin are pushing the stragglers hard — not just demanding they implement the cuts already promised, but asking for deeper curbs in the coming months to compensate for their earlier failings.“Riyadh and Moscow are not kidding about implementing some form of compliance-improvement mechanism,” said Bob McNally, founder of consultant Rapidan Energy Group and a former White House official. “Without it, they walk.”Impossible ChoiceSuch penance would be difficult for Iraq to accept. It made less than half of its assigned cutbacks last month, so compensating fully would require it to slash production by a further 24% to about 3.28 million barrels a day, according to Bloomberg calculations.For a country still rebuilding its economy following decades of war, sanctions and Islamist insurgency, that’s a tall order. Resisting the temptation of selling crude during the current market rebound, which has brought prices back to about $40 a barrel, may prove impossible.While Iraqi Finance Minister and Acting Oil Minister Ali Allawi did pledge to improve compliance with pledged cuts in an unusual Twitter post on Tuesday, he didn’t go any further.The Organization of Petroleum Exporting Countries and its allies pledged in April to slash oil output by 9.7 million barrels a day, or roughly 10% of global oil supplies, to offset the unprecedented collapse in demand caused by coronavirus lockdowns.A few weeks later, Saudi Arabia and its closest allies in the Persian Gulf promised additional supply restraint of 1.2 million barrels a day in June.Riyadh and Moscow are aligned on continuing cuts at the current level for an extra month beyond July 1, according to people familiar with the matter. But if they don’t receive assurances from Iraq and the other laggards at their next meeting — currently scheduled for June 9-10 — the group’s daily supply curbs will ease to 7.7 million barrels for the rest of the year.“Now that they’ve agreed on an extension, they’re going to turn and bring the laggards into line,” Rapidan’s McNally said on Bloomberg television Thursday. Talks with Iraq are going well, and there could be “a compliance mechanism, something formal that drags Iraq and also Nigeria into better compliance,” he said.If OPEC+ stays the course, the results could be dramatic. After the massive oil surplus earlier this year, Russian Energy Minister Alexander Novak predicts it could turn into a deficit of 3 million to 5 million barrels a day next month, Interfax reported. That’s roughly in line with projections from an OPEC committee that met on Wednesday, a delegate said.Prince’s PriorityEnforcing better compliance among OPEC+ nations has been a motif since Saudi Energy Minister Prince Abdulaziz bin Salman was appointed.In his first public outing after becoming energy minister, in Abu Dhabi last September, the prince was literally applauded for securing loud pledges of atonement from Iraq and Nigeria.But his tenure has also been stormy, and the latest move has high stakes. In March, the prince’s attempt to force Russia to make deeper output reductions backfired spectacularly, splintering the entire alliance and igniting a destructive price war.Two months ago, Prince Abdulaziz achievement in successfully restoring the OPEC+ coalition and forging an agreement for historic production cuts was delayed and ultimately overshadowed by a spat over Mexico’s contribution to the deal.Consistent LaggardIraq’s recalcitrance is as old as the OPEC+ partnership itself, which was founded in 2016 to shore up oil prices against the onslaught of American shale.Baghdad argued that the exemption from cutbacks it had received since the conflicts of the 1990s should continue. The central government also has limited influence over about 500,000 barrels a day of production from the semi-autonomous Kurdish region.At the critical meeting where OPEC+ was formed, then Oil Minister Jabbar al-Luaibi had to leave the conference room and call his prime minister for approval to accept the new strictures.The latest impasse isn’t yet showing signs of resolution. Saudi Aramco, the kingdom’s oil behemoth, has delayed the release of monthly crude prices to Sunday at the earliest, according to people with knowledge of the matter. That suggests there’s no clarity just yet on how the situation will unfold.Nonetheless, recent history suggests the burden might not be as onerous as it appears, and that Iraq’s resistance could be overcome.Last December, Baghdad was pressed to accept additional supply reductions, even though it had barely managed to cut output earlier in the year. Iraq knew it wasn’t expected to implement the entire package, but rather consider the new target as a spur to improve its performance, analysts said at the time.“It feels like Groundhog Day again as compliance issues complicate the effort to conclude a short rollover agreement,” said Helima Croft, head of commodity strategy at RBC Capital Markets LLC. “Nonetheless, we still think these issues will be resolved and that a short extension will be announced.”(Updates with Russia comments in 14th paragraph, Aramco pricing delay in 22nd.)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/2MDom1v

(Bloomberg) — Bayer AG is blocked from selling its controversial dicamba-based herbicide in the U.S. after an appeals court rejected a federal regulator’s permit for the product, compounding the German company’s weed-killer woes.The three-judge panel concluded the Environmental Protection Agency had “failed entirely” to acknowledge some risks dicamba poses and that the agency violated federal regulations when it extended its approval of registration for the herbicide for another two years in October 2018.The ruling means farmers who bought seeds to be used with dicamba for this year’s growing season may not be able to plant them, since pesticides can’t be sold or distributed in the U.S. without EPA registration. The decision is the latest blow to Bayer in the wake of its $63 billion takeover of Monsanto — a deal that made the German company a leader in agriculture products but also saddled it with a mountain of legal liabilities related to weed killers.“We strongly disagree with the ruling and are assessing our options,” Bayer spokesman Chris Loder said in an email. “If the ruling stands, we will work quickly to minimize any impact on our customers this season.”Bayer shares fell 2.7% in Frankfurt trading. The company doesn’t break down sales of individual products or their active substances and declined to comment on sales at stake. BASF SE, which also makes dicamba, was down 0.5%.‘Day of Reckoning’George Kimbrell, of the Center for Food Safety and a lawyer in the case, called the ruling “a massive win for the farmers and the environment.”“It is good to be reminded that corporations like Monsanto and the Trump Administration cannot escape the rule of law, particularly at a time of crisis like this,” Kimbrell said in an email. “Their day of reckoning has arrived.”A less volatile formulation of dicamba was originally manufactured by Monsanto after its blockbuster weed-killer Roundup began losing its effectiveness, and farmers had to increasingly deal with resistant “super weeds.”Dicamba is a central ingredient in Bayer’s XtendiMax, and can vaporize after being applied to crops and drift onto neighboring fields that aren’t resistant to the herbicide. It’s widely blamed for damaging 3.6 million acres of untreated soybeans in 2017, and more than 1 million acres in 2018.The EPA “substantially understated risks that it acknowledged” concerning dicamba’s use, the appeals court said. The ruling applies to other dicamba-based herbicides produced by BASF and Corteva Agriscience.“EPA is currently reviewing the court decision and will move promptly to address the court’s directive,” a spokesperson for the agency said.Sales HitBASF will probably lose about 80 million to 90 million euros in sales for the rest of this year ($90 million to $101 million) via its Engenia herbicide, which contains dicamba, Sebastian Bray, an analyst at Berenberg, said by email. That revenue hit will be bigger at Bayer, which also sells seeds tied to dicamba, Bray said.Dicamba will probably stay banned even if this ruling gets appealed, Bray said. Still, the EPA will probably re-authorize dicamba in a revised form in time for next year — and the agency could even move up that reauthorization before Dec. 20, when the current clearance was set to expire, Bray said.“We are reviewing the opinion, its impact on our FeXapan registration, and our next steps,” Gregg Schmidt, a spokesman for Corteva, said in an email. BASF had no immediate comment.In the first lawsuit over dicamba crop damage to go to trial, a jury in February hit Bayer and BASF with a $265 million damage award to a Missouri farmer who blamed the companies for destroying his peach orchards. Bayer is challenging the verdict.There are about 140 dicamba suits in total, and settling them could cost Bayer and BASF less than $1.5 billion, Holly Froum, an analyst with Bloomberg Intelligence, said in a note Thursday.In its ruling Wednesday, the appeals court acknowledged the “practical effects” of the decision, including the cost to farmers who have already purchased soybean and cotton seeds genetically modified to withstand dicamba and planted for the purpose of using the herbicide.The court said in addition to the environmental risks, the EPA’s registration decision on dicamba failed to recognize the “enormous social cost to farming communities” where the herbicide’s use “has turned farmer against farmer, and neighbor against neighbor.” A farmer in Arkansas was shot and killed in an argument over dicamba damage in 2016, according to the ruling.The ruling applies to the 2018 dicamba registration, which expires in December, Loder said, adding that Bayer is working on a new EPA registration for the 2021 growing season and beyond.The case is National Family Farm Coalition v. U.S. Environmental Protection Agency, 19-70115, U.S. Court of Appeals for the Ninth Circuit (San Francisco).(Updates with analyst comments in 12th paragraph)For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

from Yahoo Finance https://ift.tt/2XVxovO

LVMH, the luxury goods giant, rules out buying the jeweller's shares to get it on the cheap.

from Yahoo Finance https://ift.tt/2Xv2fjI

British luxury carmaker Aston Martin plans to shed up to 500 jobs as it seeks to bring its cost base into line with reduced sports car production levels, it said on Thursday. The job cuts come a week after Aston Martin confirmed that Tobias Moers, CEO of Mercedes-AMG, would become chief executive on August 1, replacing Andy Palmer. Aston Martin, famed for being fictional secret agent James Bond’s car of choice, has seen its share price plummet since floating in October 2018.

from Yahoo Finance https://ift.tt/2U8hfSJ